参考文献/References:
[1] Krefft S,Wolff J,Rose C,et al. Silicosis:An update and guide for clinicians[J]. Clin Chest Med，2020，41(4):709-722
[2] 中华预防医学会劳动卫生与职业病分会职业性肺部疾病学组. 尘肺病治疗中国专家共识(2018年版)[J]. 环境与职业医学,2018,35(8):677-689
[3] 中国疾病预防控制中心职业卫生与中毒控制所，浙江省医学科学院，煤炭总医院，等. 职业性尘肺病的诊断:GBZ70-2015[S]. 北京:中国标准出版社，2016:1-13
[4] 文建平，易卫平. 汉防己甲素联合大剂量N乙酰半胱氨酸治疗矽肺疗效观察[J]. 福建医药杂志，2017,39(1):98-100
[5] Barnes H,Goh N S L,Leong T L,et al. Silica associated lung disease:an old world exposure in modern industries[J]. Respirology，2019,24(12):1165-1175
[6] Pollard K M. Silica,silicosis,and autoimmunity[J]. Front immunol，2016，7(3):97
[7] 席苑,张海静,叶祖光,等. 汉防己甲素现代药理作用研究进展[J]. 中国中药杂志,2020,45(1):20-28
[8] Huang H P，Chen M J,Liu F，et al. N acetylcysteine tiheraperapeutically protects against pulmonary fibrosis in a mouse [JP2]model of silicosis[J]. Biosci Rep,2019，39(7):BSR20190681
[9] Damoiseaux J. The IL-2 IL-2 receptor pathway in health and disease:The role of the soluble IL-2 receptor[J]. Clin Immunol,2020，218(9):108515
[10] Zhang H,Sui J N,Gao L，et al. Subcutaneous administration of infliximab attenuated silica induced lung fibrosis[J]. Occup Med Environ Health,2018,31(4):503-515
[11] Lee S，Hayashi H，Mastuzaki H，et al. Silicosis and autoimmunity[J]. CurrOpin Allergy Clin Immunol，2017，17(2):78-84
[12] Zhang H,Yin G,Jing H,et al. High dose N acetylcysteine decreases silica induced lung fibrosis in the rat[J]. J Int Med Res,2013,41(4):1179-1186
[13] 肖芸,夏海玲,朱丽瑾,等. 汉防己甲素和乙酰半胱氨酸联合用药对实验性矽肺的疗效观察[J]. 中华劳动卫生职业病杂志,2015,33(7):519-522
[14] Sun J L,Song P P,Wang Y，et al. Clinical efficacy acetylcysteine combined with tetrandrine tablets in the treatment of silicosis and the effect on serum IL-6 and TNF-α[J]. Exp Ther Med，2019，18(5):3383-3388